Sort
30,917 grants matching “tumor microenvironment”
Signal Transduction Events and the Regulation of Cell Growth
$864,019Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2014 · CA
B cell determinants of EBV latency
$864,001Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · CA
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$863,755Jyothi Rengarajan · Emory University · R01 · FY2024 · AI
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$863,617Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Microenvironmental regulation of glioblastoma radiosensitivity
$863,575Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$863,419Ronald Levy · Stanford University · R35 · FY2020 · CA
Angiogenesis and Tumor Growth
$862,835Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$862,729Damian J. Green · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Tumor microenvironments determing migration, dissemination and dormancy
$862,508John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2014 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$861,992Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$861,845Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$861,166Jyothi Rengarajan · Emory University · R01 · FY2022 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$860,921Jeffrey S Miller · University Of Minnesota · R35 · FY2019 · CA
The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers
$860,909Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2020 · CA
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
$860,394Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2015 · CA
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$860,018James M Olson · Seattle Children'S Hospital · U01 · FY2023 · CA
ALTERING THE TUMOR MICROENVIRONMENT TO AUGMENT NEUROBLASTOMA IMMUNOTHERAPY
$860,000The Children'S Hospital Of Philadelphia · · FY2018 · Department of the Army
Biostatistics Core Resource
$859,715Susan G. Groshen · University Of Southern California · P30 · FY2008 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$859,480Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis
$858,638Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Signal Processing And Instrumentation Section
$858,600Thomas J Pohida · Center For Information Technology · ZIA · FY2013 · CT
CANCAN - Kaiser
$858,321Bette J Caan · Kaiser Foundation Research Institute · OT2 · FY2025 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$858,309Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Development of TGF-beta antagonists for cancer therapy
$858,227Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Decoding T cell clonotypes, biology and predictive biomarkers associated with immune checkpoint Myocarditis
$858,186Alexandra-Chloe Villani · Massachusetts General Hospital · R01 · FY2025 · AI